Interval between births and risk of congenital cytomegalovirus infection

Clinical Infectious Diseases

Volumn 38, Issue 7, 2004, Pages 1035-1037

  Fowler, Karen B ^a,c,d   Stagno, Sergio ^a,b   Pass, Robert F ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONCEPTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DELIVERY; FAMILY PLANNING; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRENATAL CARE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS INFECTION; VIRUS TRANSMISSION; BIRTH; CYTOMEGALIC INCLUSION BODY DISEASE; DISEASE TRANSMISSION; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; STATISTICS; VIROLOGY;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 1842503218     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/382533     Document Type: Article

References (15)

1. Stagno S, Pass RF, Dworsky ME, Alford CA. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982; 25: 563-76.
2. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256:1904-8.
3. Jordan MC, Rousseau W, Stewart JA, Noble GR, Chin TD. Spontaneous cytomegalovirus mononucleosis: clinical and laboratory observations in nine cases. Ann Intern Med 1973; 79:153-60.
4. Pass RF, Stagno S, Dworsky ME, Smith RJ, Alford CA. Excretion of cytomegalovirus in mothers: observation after delivery of congenitally infected and normal infants. J Infect Dis 1982; 146:1-6.
5. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999; 180:702-7.
6. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003; 289:1008-11.
7. Balcarek KB, Warren W, Smith RJ, Lyon MD, Pass RF. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis 1993; 167:1433-6.
8. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999; 282:531-8.
9. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344:1366-71.
10. American College of Obstetricians and Gynecologists (ACOG). ACOG practice bulletin: perinatal viral and parasitic infections. Washington, DC: ACOG, 2000.
11. Grangeot-Keros L, Simon B, Audibert F, Vial M. Should we routinely screen for cytomegalovirus antibody during pregnancy? Intervirology 1998; 41:158-62.
12. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15:680-715.
13. Audibert F. For or against routine CMV screening in the pregnant woman? Are there arguments for routine screening for maternal-fetal CMV infection? Gynecol Obstet Fertil 2002; 30:994-8.
14. Goffinet F. For or against routine CMV screening in the pregnant woman? Are there arguments for routine screening for maternal-fetal CMV infection? Gynecol Obstet Fertil 2002; 30:998-1004.
15. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000; 137:90-5.